Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(645/week)
Manufacturing
(458/week)
Energy
(363/week)
Technology
(468/week)
Other Manufacturing
(374/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Cancer treatments
Apr 27, 2020
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma
Apr 27, 2020
Innovent Announces First Patient Dosed in a Pivotal Trial of Parsaclisib in Patients with Indolent Lymphoma in China
Apr 23, 2020
New Early Breast Cancer Drug Available Now In Singapore
Apr 23, 2020
SITC Announces Three Recipients of the 2020 Richard V. Smalley, MD, Memorial Award and Lectureship
Apr 23, 2020
Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
Apr 22, 2020
Novartis Kymriah® receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Apr 22, 2020
Alkermes Announces Publication of Preclinical Data for ALKS 4230 in the Journal for ImmunoTherapy of Cancer
Apr 22, 2020
Pancreatic Cancer Cells Hijack Basic Cell Mechanism to Evade Immunotherapy
Apr 21, 2020
IMBRUVICA® (ibrutinib) Receives 11th FDA Approval
Apr 20, 2020
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic
Apr 17, 2020
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma | US & EU Market Sizes from 2017 to 2030, Details of Marketed & Emerging Therapies Kymriah (Novartis) & KTE-X19 (Gilead Sciences)
Apr 16, 2020
Alphamab Oncology Received U.S. FDA IND Approval to Initiate A Phase II Clinical Trial of KN046 For NSCLC in the United States
Apr 16, 2020
Long Term Analytical Validation Study Further Confirms BluePrint as a Reliable Genomic Profiling Assay for Early Stage Breast Cancer Patients
Apr 15, 2020
Portage provides update on portfolio company, Intensity Therapeutics, Inc.
Apr 13, 2020
Gracell to Present the First-in-human, Universal TruUCAR(TM) GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting
Apr 09, 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Apr 07, 2020
Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study
Apr 07, 2020
GenScript ProBio and Eutilex Enter into Exclusive Strategic Collaboration on Plasmid and Virus Process Development and Manufacturing for CAR-T Programs
Apr 06, 2020
GAC Beneficiary Houston Methodist Investigates Immunotherapy Techniques to Curb COVID-19
Apr 03, 2020
Gracell Announces China MNPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
‹‹
Page 6
››
Latest News
May 8, 2024
Cemex Tops Industry in 2024 Climate and Energy Benchmark
May 8, 2024
M-tron Industries, Inc. Reports First Quarter 2024 Results and Reminds Stakeholders of Investor Day
May 8, 2024
ExxonMobil elects Maria Jelescu Dreyfus to Board of Directors
May 8, 2024
Sturm, Ruger & Company, Inc. Reports First Quarter Diluted Earnings of 40¢ Per Share and Declares...
May 8, 2024
USD Partners LP Announces Quarterly Unaudited Financial Statements for the Quarter Ended March 31, 2024
May 8, 2024
Exchange Income Corporation Generates Record First Quarter Results and Celebrates 20 Years of Continued...
May 8, 2024
Berry Declares Quarterly Dividend
May 8, 2024
Archer Aviation Inc. to Present at Upcoming Investor Conferences
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events